Singapore markets close in 4 hours 48 minutes

Exagen Inc. (XGN)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.8700-0.0300 (-1.58%)
At close: 04:00PM EDT
1.8400 -0.03 (-1.60%)
After hours: 05:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9000
Open1.8900
Bid1.8400 x 100
Ask1.9200 x 100
Day's range1.8001 - 1.9708
52-week range1.3000 - 3.4710
Volume40,197
Avg. volume48,759
Market cap33.01M
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

    CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2024. First Quarter Highlights: Recognized total revenue of $14.4 million in the first quarter of 2024, a 28.4% increase over the first quarter of 2023.Delivered gross margin of 59.6% in the first quarter of 2024, compared to a gross margin of 47.2% in the first quarter of 2023. AVISE® CTD trailing twelv

  • GlobeNewswire

    Exagen Announces Campaign for Lupus Awareness Month

    CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work being done to help those suffering from Systemic Lupus Erythematosus (SLE). Lupus Awareness Month occurs every May and is an important platform for lupus-focused organizations to educate and advoc

  • GlobeNewswire

    Exagen to Announce First Quarter 2024 Results on May 13, 2024

    CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on Monday, May 13, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 AM ET (5:30 AM PT). Interested parties may access the conference call by dialing (201) 38